Moderna issues patent for its coronavirus vaccine for the duration of the pandemic | the Chronicle

The laboratory Modern, one of the pioneering companies in creating the coronavirus vaccine, said in a statement that it will not enforce vaccine-related patents Covid-19, to companies that also manufacture it during the pandemic.

“As long as the pandemic continues, at Moderna we will not apply our COVID-19 related patents against those who manufacture vaccines designed to fight the pandemic “, the company stated in the brief.

The Yankee city of Cambridge company said it was an effort not to deter other companies that are investigating the development of similar vaccines.

The idea was born after the investorsIts noted that the company has patents that could be applied to other SARS-CoV-2 inoculations, Moderna president Stephen Hoge said in an interview.

This comes in a week where there was a debate on whether or not patents should be published.

Over the past few weeks, there has been debate as to whether or not the patents for the coronavirus vaccines should be published.

Patents are an assurance for the company concerning the period of exclusivity and the advantages of having its own market without direct competitors.

The first presentation took place in October 2020, as part of an initiative signed by India and South Africa with more than 100 countriesBut at the time, the European Union and Switzerland opposed it.